Cargando…
Microbial and fungal protease inhibitors—current and potential applications
Proteolytic enzymes play essential metabolic and regulatory functions in many biological processes and also offer a wide range of biotechnological applications. Because of their essential roles, their proteolytic activity needs to be tightly regulated. Therefore, small molecules and proteins that in...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080157/ https://www.ncbi.nlm.nih.gov/pubmed/22218770 http://dx.doi.org/10.1007/s00253-011-3834-x |
_version_ | 1783507972158128128 |
---|---|
author | Sabotič, Jerica Kos, Janko |
author_facet | Sabotič, Jerica Kos, Janko |
author_sort | Sabotič, Jerica |
collection | PubMed |
description | Proteolytic enzymes play essential metabolic and regulatory functions in many biological processes and also offer a wide range of biotechnological applications. Because of their essential roles, their proteolytic activity needs to be tightly regulated. Therefore, small molecules and proteins that inhibit proteases can be versatile tools in the fields of medicine, agriculture and biotechnology. In medicine, protease inhibitors can be used as diagnostic or therapeutic agents for viral, bacterial, fungal and parasitic diseases as well as for treating cancer and immunological, neurodegenerative and cardiovascular diseases. They can be involved in crop protection against plant pathogens and herbivorous pests as well as against abiotic stress such as drought. Furthermore, protease inhibitors are indispensable in protein purification procedures to prevent undesired proteolysis during heterologous expression or protein extraction. They are also valuable tools for simple and effective purification of proteases, using affinity chromatography. Because there are such a large number and diversity of proteases in prokaryotes, yeasts, filamentous fungi and mushrooms, we can expect them to be a rich source of protease inhibitors as well. |
format | Online Article Text |
id | pubmed-7080157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-70801572020-03-23 Microbial and fungal protease inhibitors—current and potential applications Sabotič, Jerica Kos, Janko Appl Microbiol Biotechnol Mini-Review Proteolytic enzymes play essential metabolic and regulatory functions in many biological processes and also offer a wide range of biotechnological applications. Because of their essential roles, their proteolytic activity needs to be tightly regulated. Therefore, small molecules and proteins that inhibit proteases can be versatile tools in the fields of medicine, agriculture and biotechnology. In medicine, protease inhibitors can be used as diagnostic or therapeutic agents for viral, bacterial, fungal and parasitic diseases as well as for treating cancer and immunological, neurodegenerative and cardiovascular diseases. They can be involved in crop protection against plant pathogens and herbivorous pests as well as against abiotic stress such as drought. Furthermore, protease inhibitors are indispensable in protein purification procedures to prevent undesired proteolysis during heterologous expression or protein extraction. They are also valuable tools for simple and effective purification of proteases, using affinity chromatography. Because there are such a large number and diversity of proteases in prokaryotes, yeasts, filamentous fungi and mushrooms, we can expect them to be a rich source of protease inhibitors as well. Springer-Verlag 2012-01-05 2012 /pmc/articles/PMC7080157/ /pubmed/22218770 http://dx.doi.org/10.1007/s00253-011-3834-x Text en © Springer-Verlag 2012 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Mini-Review Sabotič, Jerica Kos, Janko Microbial and fungal protease inhibitors—current and potential applications |
title | Microbial and fungal protease inhibitors—current and potential applications |
title_full | Microbial and fungal protease inhibitors—current and potential applications |
title_fullStr | Microbial and fungal protease inhibitors—current and potential applications |
title_full_unstemmed | Microbial and fungal protease inhibitors—current and potential applications |
title_short | Microbial and fungal protease inhibitors—current and potential applications |
title_sort | microbial and fungal protease inhibitors—current and potential applications |
topic | Mini-Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080157/ https://www.ncbi.nlm.nih.gov/pubmed/22218770 http://dx.doi.org/10.1007/s00253-011-3834-x |
work_keys_str_mv | AT saboticjerica microbialandfungalproteaseinhibitorscurrentandpotentialapplications AT kosjanko microbialandfungalproteaseinhibitorscurrentandpotentialapplications |